Stock listing

Frankfurt:2K3 SI-BONE, Inc. Aktie

German listing (Frankfurt) of SI-BONE, Inc. · home listing NASDAQ:SIBN

Follow SI-BONE, Inc. into a list and get an email when it puts out news.

Share price · FWB:2K3

€17.51 EUR +0.02 (+0.1%)

Close on Nov 5, 2026

Past year +34.6% · daily closes, Nov 5, 2025 – Nov 5, 2026, adjusted for splits
Day range
€17.51 – €17.51 EURNov 5, 2026
Market cap
€784.7M EURAt the close on Nov 5, 2026 · price × 44.82M shares outstanding
52-week range
€9.73 – €19.72 EURLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
Traded on an average day
€0 EURMedian day 0 shares · 67 days with no trades · last 3 months, Aug 5, 2026 – Nov 5, 2026
SI-BONE, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SIBN · Home$23.73 USD+0.19 (+0.8%)801,083$23.55$24.40$23.53$23.54Close on Nov 20, 2026
Frankfurt:2K3€17.51 EUR+0.017 (+0.1%)—€17.51€17.51€17.51€17.49Close on Nov 5, 2026

Daily closes

Last 3 months, Aug 5, 2026 – Nov 5, 2026 · FWB:2K3 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€17.51+0.017+0.1%€17.51€17.51€17.510
€17.49-0.126-0.7%€17.49€17.49€17.490
€17.62-1.012-5.4%€17.64€17.67€17.590
€18.63-0.857-4.4%€18.56€18.83€18.450
€19.49+0.074+0.4%€19.54€19.72€19.380
€19.41+0.102+0.5%€19.28€19.55€19.060
€19.31+0.667+3.6%€18.79€19.37€18.780
€18.64-0.373-2.0%€18.64€18.64€18.640
€19.02+0.32+1.7%€18.80€19.03€18.630
€18.70+0.702+3.9%€18.73€18.77€18.690
€18.00+0.122+0.7%€18.00€18.00€18.000
€17.87+0.696+4.1%€17.81€18.01€17.690
€17.18+0.182+1.1%€17.18€17.18€17.180
€17.00-0.325-1.9%€17.00€17.00€17.000
€17.32+0.385+2.3%€17.32€17.32€17.320
€16.94-0.156-0.9%€17.04€17.09€16.910
€17.09-0.547-3.1%€17.09€17.09€17.090
€17.64+0.732+4.3%€17.63€17.84€17.430
€16.91+0.595+3.6%€16.91€16.91€16.910
€16.31-0.255-1.5%€16.31€16.31€16.310
€16.57-0.022-0.1%€16.65€16.73€16.570
€16.59-0.748-4.3%€17.02€17.11€16.470
€17.34+1.405+8.8%€17.34€17.34€17.340
€15.93-0.092-0.6%€15.80€15.94€15.700
€16.02-0.326-2.0%€16.01€16.08€15.800
€16.35-0.09-0.5%€16.15€16.42€16.060
€16.44+0.331+2.1%€16.49€16.54€16.440
€16.11+0.263+1.7%€16.11€16.11€16.110
€15.85-0.12-0.8%€15.94€16.16€15.850
€15.97+0.179+1.1%€15.88€16.12€15.770
€15.79-0.214-1.3%€15.79€15.79€15.790
€16.00+0.348+2.2%€16.03€16.06€15.900
€15.65+0.133+0.9%€15.71€15.71€15.650
€15.52+0.272+1.8%€15.44€15.61€15.400
€15.25-0.645-4.1%€15.32€15.38€15.250
€15.89+0.266+1.7%€15.84€15.97€15.710
€15.63-0.205-1.3%€15.63€15.63€15.630
€15.83+0.305+2.0%€15.83€15.83€15.830
€15.53+0.058+0.4%€15.46€15.73€15.360
€15.47+0.049+0.3%€15.43€15.67€15.260
€15.42-0.181-1.2%€15.42€15.42€15.420
€15.60+0.086+0.6%€15.60€15.60€15.600
€15.510.000.0%€15.51€15.51€15.510
€15.51-0.067-0.4%€15.51€15.51€15.510
€15.58-0.561-3.5%€15.47€15.83€15.450
€16.14+0.045+0.3%€16.22€16.24€16.140
€16.10+0.087+0.5%€15.94€16.15€15.920
€16.01-0.057-0.4%€16.01€16.01€16.010
€16.07-0.086-0.5%€16.07€16.12€16.030
€16.15-0.064-0.4%€16.15€16.15€16.150
€16.22-0.045-0.3%€16.22€16.22€16.220
€16.26-0.159-1.0%€16.46€16.58€16.230
€16.42-0.473-2.8%€16.18€16.42€16.150
€16.89+0.619+3.8%€16.60€16.95€16.560
€16.28-0.204-1.2%€16.20€16.34€16.130
€16.48+0.374+2.3%€16.48€16.48€16.480
€16.11+0.407+2.6%€16.11€16.11€16.110
€15.70-0.127-0.8%€15.70€15.70€15.700
€15.83-0.192-1.2%€15.83€15.83€15.830
€16.02-0.314-1.9%€16.02€16.02€16.020
€16.33+0.628+4.0%€16.21€16.35€16.190
€15.70-0.304-1.9%€15.92€15.98€15.680
€16.01+0.518+3.3%€16.02€16.12€16.010
€15.49+0.196+1.3%€15.61€15.71€15.470
€15.29+0.522+3.5%€15.39€15.41€15.260
€14.77-0.862-5.5%€15.07€15.17€14.670
€15.63+0.896+6.1%€15.63€15.63€15.630
Ticker
Frankfurt:2K3
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All SI-BONE, Inc. news

SI-BONE, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
18 in the last 12 months · 145 in all · newest Nov 19, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Nov 2, 2026
Decks
8 decks · latest Aug 3, 2026

Where SI-BONE, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SIBN · Home listingNASDAQUnited StatesUSD
LS Exchange:A2N7LYLS ExchangeGermanyEUR
BOATS:SIBNBOATSUnited StatesUSD
gettex:2K3gettexGermanyEUR
Dusseldorf:2K3DusseldorfGermanyEUR
Frankfurt:2K3 · This pageFrankfurtGermanyEUR
Lang & Schwarz:A2N7LYLang & SchwarzGermanyEUR
Munich:2K3MunichGermanyEUR
Stuttgart:2K3StuttgartGermanyEUR
Tradegate:2K3TradegateGermanyEUR

Valuation

EV/sales 4.8× against a median of 3.9×: 8th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.07B USD
P/E
Loss
EV/sales
4.8×
EV/EBITDA
Negative EBITDA
Price/book
5.8×
Gross margin
79.4%
Operating margin
−7.6%
Net margin
−6.2%
Debt to equity
0.2×
Beta vs S&P 500
0.62

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
SI-BONE, Inc. · NASDAQ:SIBNUS$1.07BUS$1.07Bn/a4.8×n/a5.8×−6.2%0.2×0.62
Eyebright Medical Technology (Beijing) Co., Ltd. Class A · SSE:688050US$1.18BUS$1.21B32.6×4.5×n/a2.6×13.5%0.3×n/a
Shandong Weigao Orthopaedic Device Co., Ltd. Class A · SSE:688161US$1.09BUS$897.1M30.3×4.3×n/a1.7×17.2%0.0×n/a
CeriBell, Inc. · NASDAQ:CBLLUS$1.06BUS$967.9Mn/a8.9×n/a9.1×−68.0%0.2×0.82
CLASSYS Inc. · KRX:214150US$1.06BUS$959.3M10.3×3.5×7.0×2.6×37.3%0.0×n/a
Shinva Medical Instrument Co. Ltd. Class A · SSE:600587US$1.04BUS$608.1M15.3×0.4×n/a0.9×4.5%0.0×n/a
Alphatec Holdings, Inc. · NASDAQ:ATECUS$1.04BUS$1.51Bn/a1.8×31.6×n/a−10.3%n/a1.26
iRadimed Corporation · NASDAQ:IRMDUS$1.04BUS$972.8M43.2×10.9×31.9×9.7×26.9%0.0×0.65
Integra LifeSciences Holdings Corporation · NASDAQ:IARTUS$1.03BUS$1.42B79.2×0.8×n/a1.0×0.8%0.7×1.47
Draegerwerk AG & Co. KGaA · XETR:DRW8US$985.7MUS$911.1M5.3×0.2×2.0×0.5×4.7%0.1×n/a
Shenzhen Edge Medical Co., Ltd. Class H · HKEX:2675US$973.0MUS$695.3Mn/a10.2×n/a2.8×−19.4%0.0×n/a
Median of the othersUS$1.04BUS$963.6M30.3×3.9×19.3×2.6×4.6%0.0×1.04

Forecasts

6 strong buy · 3 buy · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
26.44 USD · Analysts' mean
EPS, year to Dec 2026
-0.34 · 7 analysts
Revenue, year to Dec 2026
232.1M · 9 analysts

Team and board

Officers

OfficerRole
Laura A. FrancisChief Executive Officer
Mark ReileyFounder

Board

DirectorRole
Jeffrey W. DunnChairman of the Board
Jeryl Lynn HillemanDirector
John G. FreundDirector
Laura A. FrancisChief Executive Officer
Mika NishimuraDirector
Thomas A. WestDirector
Timothy E. DavisDirector

Events

Calls

CallWhenStatus
SI-BONE (NASDAQ:SIBN) Q3 2026 Earnings CallMon, Nov 02, 2026 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q2 2026 Earnings CallMon, Aug 03, 2026 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q1 2026 Earnings CallMon, May 11, 2026 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q4 2025 Earnings CallMon, Feb 23, 2026 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q3 2025 Earnings CallMon, Nov 10, 2025 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q2 2025 Earnings CallMon, Aug 04, 2025 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q1 2025 Earnings CallMon, May 05, 2025 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q4 2024 Earnings CallMon, Feb 24, 2025 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q3 2024 Earnings CallTue, Nov 12, 2024 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q2 2024 Earnings CallMon, Aug 05, 2024 · 4:30 PM ETReplay
All 25 calls
CallWhenStatus
SI-BONE (NASDAQ:SIBN) Q1 2024 Earnings CallMon, May 06, 2024 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q4 2023 Earnings CallMon, Feb 26, 2024 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q3 2023 Earnings CallMon, Nov 06, 2023 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q2 2023 Earnings CallMon, Aug 07, 2023 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q1 2023 Earnings CallMon, May 01, 2023 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q4 2022 Earnings CallMon, Feb 27, 2023 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q3 2022 Earnings CallMon, Nov 07, 2022 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q1 2022 Earnings CallMon, May 09, 2022 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q4 2021 Earnings CallMon, Feb 28, 2022 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q3 2021 Earnings CallMon, Nov 08, 2021 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q2 2021 Earnings CallMon, Aug 02, 2021 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q1 2021 Earnings CallMon, May 03, 2021 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q4 2020 Earnings CallMon, Mar 08, 2021 · 4:30 PM ETReplay
SI-BONE (NASDAQ:SIBN) Q3 2020 Earnings CallMon, Nov 02, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 2, 2026 · After close+17.6%
Q2 2026Aug 3, 2026 · After close−0.1%
Q1 2026May 11, 2026 · After close+19.7%
Q4 2025Feb 23, 2026 · After close−2.1%
Q3 2025Nov 10, 2025 · After close+16.2%
Q2 2025Aug 4, 2025 · After close−10.6%
Q1 2025May 5, 2025 · After close+15.4%
Q4 2024Feb 24, 2025 · Before open−2.1%
Q3 2024Nov 12, 2024 · After close−15.9%
Q2 2024Aug 5, 2024 · After close+1.3%
All 20 quarters
QuarterResultsShare move
Q1 2024May 6, 2024 · After close+8.3%
Q4 2023Feb 26, 2024 · After close−13.5%
Q3 2023Nov 6, 2023 · After close−2.1%
Q2 2023Aug 7, 2023 · After close−11.2%
Q1 2023May 1, 2023 · After close+7.2%
Q4 2022Feb 27, 2023 · After close+16.7%
Q3 2022Nov 7, 2022 · After close−24.3%
Q2 2022Aug 8, 2022 · After close−5.5%
Q1 2022May 9, 2022 · After close−12.7%
Q4 2021Feb 28, 2022 · After close−1.0%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings27 slidesAug 3, 2026
Q4 2025 Earnings PresentationEarnings31 slidesFeb 23, 2026
Investor Presentation (January 2026)Investor deck26 slidesJan 12, 2026
Investor Presentation (January 2024)Investor deck24 slidesJan 8, 2024
Investor Presentation (January 2023)Investor deck25 slidesJan 9, 2023
Investor Presentation (January 2022)Investor deck26 slidesJan 10, 2022
Investor Presentation (January 2021)Investor deck28 slidesJan 7, 2021
Investor Presentation (January 2020)Investor deck28 slidesJan 9, 2020

Open Decks

IPO

Priced at US$15.00 a share on Oct 16, 2018.

Price
US$15.00 a share
Shares offered
7,200,000 shares of common stock
Offering size
US$108 million
Underwriters' option
Up to 1,080,000 more shares
Underwriters
Morgan Stanley, BofA Merrill Lynch, Canaccord Genuity, JMP Securities · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceAug 6, 2015
Filed publiclySep 20, 2018
Amended onceOct 5, 2018
Shares registered with an exchangeOct 11, 2018
Declared effective by the SECOct 16, 2018
Final prospectus, with the priceOct 18, 2018

Open IPO · From the cover of the final prospectus (424B4) filed Oct 18, 2018

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue200.9M167.2M138.9M106.4M90.2M73.4M67.3M55.4M48.0M
Cost of revenue41.0M35.1M29.5M15.7M10.4M8.90M6.79M4.83M5.11M
Gross profit159.9M132.1M109.4M90.7M79.7M64.5M60.5M50.5M42.9M
Research and development17.4M16.6M15.0M13.6M12.4M9.46M7.28M5.38M5.51M
Operating income-22.3M-35.2M-46.9M-59.6M-51.7M-38.6M-36.0M-12.0M-17.4M
Depreciation and amortization5.77M4.38M5.43M3.45M2.09M1.13M774.0K722.0K1.01M
EBITDA-16.6M-30.9M-41.5M-56.2M-49.6M-37.4M-35.2M-11.2M-16.3M
Interest expense2.63M3.44M3.46M2.82M5.37M6.10M4.95M5.11M6.20M
Income before tax-19.1M-31.1M-43.5M-61.4M-57.0M-43.7M-38.4M-17.5M-23.0M
Income tax0000000
Net income-18.9M-30.9M-43.3M-61.3M-56.6M-43.7M-38.4M-17.5M-23.0M
Earnings per share, basic-0.44-0.75-1.13-1.79-1.71-1.50-1.55-2.20-6.65
Earnings per share, diluted-0.44-0.75-1.13-1.79-1.71-1.50-1.55-2.20-6.65

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents42.2M34.9M33.3M20.7M63.4M53.6M10.4M25.1M22.4M
Short-term investments76.6M83.6M142.9M81.3M97.1M
Receivables29.9M27.5M22.0M20.7M14.2M13.6M11.7M8.49M7.42M
Inventory33.9M27.1M20.2M17.3M11.5M5.63M5.45M3.34M2.55M
Current assets216.1M207.8M211.4M137.6M175.9M218.2M111.5M136.0M33.6M
Property, plant and equipment21.3M20.4M16.0M15.6M8.99M4.53M3.95M2.15M1.90M
Total assets238.6M230.4M230.4M157.6M190.5M223.1M117.0M138.5M35.8M
Accounts payable4.63M6.49M4.59M6.28M3.20M3.27M2.81M2.15M1.81M
Current liabilities25.3M27.1M23.5M21.2M16.9M13.5M18.8M9.01M7.54M
Long-term debt35.6M35.5M36.1M35.2M35.0M39.5M34.9M39.0M38.7M
Total debt35.6M35.5M36.1M35.2M35.0M39.5M39.2M39.0M38.7M
Total liabilities61.0M63.5M61.0M59.3M56.1M53.8M54.0M48.3M46.7M
Shareholders' equity177.5M167.0M169.4M98.3M134.4M169.4M63.0M90.2M-129.4M
Shares outstanding43.6M42.1M40.7M34.7M33.7M32.6M25.2M24.5M3.60M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-675.0K-12.4M-18.7M-41.7M-39.5M-30.7M-31.6M-14.5M-17.5M
Capital spending-8.41M-10.5M-7.80M-9.51M-6.39M-2.56M-2.44M-942.0K-478.0K
Free cash flow-9.09M-22.9M-26.5M-51.2M-45.9M-33.2M-34.1M-15.5M-18.0M
Cash from investing4.16M12.6M-59.8M-2.81M51.6M-62.9M13.5M-97.8M-478.0K
Cash from financing3.38M1.96M90.9M2.20M-1.71M136.4M3.49M115.2M12.9M
Share buybacks-38.0K-73.0K0
Change in cash7.29M1.68M12.6M-42.7M9.84M43.1M-14.7M2.71M-5.49M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
144 · Notice of proposed saleNov 17, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
4/A · Change in ownership, amendedNov 9, 2026Insider tradeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipNov 4, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleNov 4, 2026Other filingsSEC
144 · Notice of proposed saleNov 4, 2026Other filingsSEC
144 · Notice of proposed saleNov 4, 2026Other filingsSEC
10-Q · Quarterly reportNov 3, 2026Quarterly reportSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
8-K · Current reportNov 2, 2026ResultsSEC
144 · Notice of proposed saleOct 29, 2026Other filingsSEC
144 · Notice of proposed saleOct 29, 2026Other filingsSEC
4 · Change in ownershipOct 14, 2026Insider tradeSEC
144 · Notice of proposed saleOct 13, 2026Other filingsSEC
4 · Change in ownershipOct 6, 2026Insider tradeSEC
4 · Change in ownershipOct 6, 2026Insider tradeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
144 · Notice of proposed saleOct 5, 2026Other filingsSEC
8-K · Current reportSep 11, 2026Material contractSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipAug 26, 2026Insider tradeSEC
4 · Change in ownershipAug 26, 2026Insider tradeSEC
144 · Notice of proposed saleAug 24, 2026Other filingsSEC
144 · Notice of proposed saleAug 24, 2026Other filingsSEC
4 · Change in ownershipAug 21, 2026Insider tradeSEC
4 · Change in ownershipAug 21, 2026Insider tradeSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
144 · Notice of proposed saleAug 20, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
10-Q · Quarterly reportAug 4, 2026Quarterly reportSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
8-K · Current reportAug 3, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 30, 2026Big-stake noticeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
8-K · Current reportJun 8, 2026Material contractSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
144 · Notice of proposed saleMay 29, 2026Other filingsSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
10-Q · Quarterly reportMay 11, 2026Quarterly reportSEC
8-K · Current reportMay 11, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 7, 2026Big-stake noticeSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 24, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 21, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 21, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 21, 2026Meeting noticeSEC
4 · Change in ownershipApr 9, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
S-8 · Registration statement for employee plansFeb 24, 2026Offer documentSEC
S-3ASR · Registration statementFeb 24, 2026Offer documentSEC
10-K · Annual reportFeb 24, 2026Annual reportSEC
8-K · Current reportFeb 23, 2026ResultsSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 12, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipJan 12, 2026Insider tradeSEC
8-K · Current reportJan 12, 2026ResultsSEC
144 · Notice of proposed saleJan 8, 2026Other filingsSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
144 · Notice of proposed saleJan 2, 2026Other filingsSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
144 · Notice of proposed saleDec 8, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeDec 5, 2025Big-stake noticeSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 21, 2025Other filingsSEC
144 · Notice of proposed saleNov 21, 2025Other filingsSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
144 · Notice of proposed saleNov 18, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
10-Q · Quarterly reportNov 10, 2025Quarterly reportSEC
8-K · Current reportNov 10, 2025ResultsSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
4 · Change in ownershipOct 6, 2025Insider tradeSEC
4 · Change in ownershipOct 6, 2025Insider tradeSEC
4 · Change in ownershipOct 6, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 12, 2025Big-stake noticeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
4 · Change in ownershipAug 6, 2025Insider tradeSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 4, 2025ResultsSEC
4/A · Change in ownership, amendedJul 22, 2025Insider tradeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
144 · Notice of proposed saleJul 7, 2025Other filingsSEC
144 · Notice of proposed saleJul 3, 2025Other filingsSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
8-K · Current reportJun 6, 2025Meeting outcomeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
144 · Notice of proposed saleMay 19, 2025Other filingsSEC
144 · Notice of proposed saleMay 19, 2025Other filingsSEC
144 · Notice of proposed saleMay 16, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
144 · Notice of proposed saleMay 12, 2025Other filingsSEC
4 · Change in ownershipMay 9, 2025Insider tradeSEC
4 · Change in ownershipMay 9, 2025Insider tradeSEC
144 · Notice of proposed saleMay 8, 2025Other filingsSEC
144 · Notice of proposed saleMay 7, 2025Other filingsSEC
144 · Notice of proposed saleMay 7, 2025Other filingsSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
8-K · Current reportMay 5, 2025ResultsSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
ARS · Annual report to shareholdersApr 25, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 25, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 25, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 18, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 17, 2025Big-stake noticeSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 24, 2025Insider tradeSEC
S-8 · Registration statement for employee plansFeb 25, 2025Offer documentSEC
10-K · Annual reportFeb 25, 2025Annual reportSEC
8-K · Current reportFeb 24, 2025ResultsSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 5, 2025Insider tradeSEC
4 · Change in ownershipFeb 5, 2025Insider tradeSEC
4 · Change in ownershipFeb 5, 2025Insider tradeSEC
4 · Change in ownershipFeb 5, 2025Insider tradeSEC
8-K · Current reportJan 13, 2025ResultsSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
144 · Notice of proposed saleNov 19, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K · Current reportNov 12, 2024ResultsSEC

This page holds 200 of 791 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from SI-BONE, Inc.’s releases · as of Oct 28, 2026

Common shares
45,113,087
Fully diluted
45,113,087

Fully diluted

LineSharesAs of
Common shares45,113,087Oct 28, 2026

Share count over time

CountShares
Oct 28, 202645,113,087

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
First Light Asset Management, LLC7.69MUS$145M−441KNov 16, 2026
Cadian Capital Management, LP3.79MUS$71.3M+444KNov 16, 2026
BlackRock3.72MUS$70M+47,573Nov 13, 2026
Vanguard2.83MUS$53.1M+99,561Nov 13, 2026
American Century2.52MUS$47.4M+9,871Nov 20, 2026
Brown Advisory Inc1.95MUS$36.7M−126KNov 16, 2026
Impax Asset Management Group plc1.43MUS$26.8MNo changeNov 10, 2026
Gilder Gagnon Howe & Co LLC1.33MUS$24.9M+72,252Nov 16, 2026
Nuveen1.32MUS$24.9M+298KNov 10, 2026
State Street1.24MUS$23.4M+28,143Nov 12, 2026
Show 50 holders
HolderSharesValueChange vs Jun 30Filed
Paradigm Capital Management Inc1.23MUS$23.1M−5,000Nov 13, 2026
Geode Capital1.13MUS$21.2M+49,175Nov 6, 2026
Granahan Investment Management, LLC1.11MUS$20.9M−819KNov 16, 2026
Silvercrest Asset Management Group LLC1.06MUS$19.8M−103KNov 16, 2026
Millennium927KUS$17.4M+563KNov 16, 2026
Next Century Growth Investors LLC779KUS$14.6M+194KNov 13, 2026
First Eagle Investment Management, LLC772KUS$14.5M−766KNov 10, 2026
Champlain Investment Partners, LLC755KUS$14.2M−141KNov 12, 2026
Dimensional732KUS$13.8M+23,979Nov 4, 2026
Marshall Wace, LLP698KUS$13.1M+8,128Nov 13, 2026
Point72 Asset Management, L.P.620KUS$11.7M−170KNov 16, 2026
Goldman Sachs483KUS$9.08M+41,117Nov 16, 2026
Bank of America467KUS$8.77M+45,131Nov 16, 2026
Royce & Associates LP457KUS$8.59M+62,000Nov 9, 2026
Northern Trust449KUS$8.43M+9,380Nov 16, 2026
Peregrine Capital Management LLC437KUS$8.21M+29,204Nov 9, 2026
HighMark Wealth Management LLC425KUS$7.99MNo changeNov 16, 2026
Victory Capital403KUS$7.57M+258KNov 10, 2026
Parkman Healthcare Partners LLC393KUS$7.38M+64,117Nov 16, 2026
Schwab392KUS$7.38M+49,566Nov 16, 2026
D. E. Shaw & Co., Inc.308KUS$5.8M+122KNov 16, 2026
Sei Investments Co305KUS$5.73M+30,103Nov 10, 2026
Tocqueville Asset Management L.P.304KUS$5.72MNo changeNov 13, 2026
UBS290KUS$5.45M+98,489Nov 16, 2026
Pier Capital, LLC275KUS$5.18M+11,622Nov 13, 2026
Essex Investment Management Co LLC263KUS$4.95M−8,303Oct 19, 2026
ArrowMark Colorado Holdings LLC259KUS$4.88MNewNov 16, 2026
AQR Capital Management LLC255KUS$4.79M+731Nov 16, 2026
Morgan Stanley254KUS$4.78M+124KNov 13, 2026
Hrt Financial LP251KUS$4.73M+229KNov 13, 2026
Harbor Capital Advisors, Inc.201KUS$3.78M−68,435Oct 22, 2026
VELA Investment Management, LLC199KUS$3.75M−1,687Nov 9, 2026
Citadel186KUS$3.51MNewNov 16, 2026
Citigroup Inc171KUS$3.21M+80,547Nov 4, 2026
Tudor Investment Corp Et Al160KUS$3.01M+28,762Nov 16, 2026
Cinctive Capital Management LP156KUS$2.92M+32,049Nov 16, 2026
Amundi155KUS$2.91MNewNov 6, 2026
Nomura148KUS$2.77M+14,440Nov 16, 2026
Trexquant Investment LP146KUS$2.75M+75,624Nov 16, 2026
Bullseye Asset Management LLC131KUS$2.47M−13,071Nov 13, 2026

This page holds 50 of 170 holders. Open Shareholders

Funds

HolderSharesValueChangeAs of
Small Cap Growth Fund1.9MUS$33.7MNo changeJul 31, 2026
Impax Small Cap Fund1.43MUS$23.3MNo changeJun 30, 2026
Vanguard Total Stock Market Index Fund1.34MUS$21.8M+51,700Jun 30, 2026
iShares Russell 2000 ETF1.14MUS$18.6M+198KJun 30, 2026
First Eagle Small Cap Opportunity Fund673KUS$12M+55,303Jul 31, 2026
College Retirement Equities Fund - Total Global Stock Account578KUS$9.44M−210KJun 30, 2026
JNL Multi-Manager Small Cap Growth Fund549KUS$8.97M+65,806Jun 30, 2026
Fidelity Small Cap Index Fund480KUS$8.53M+99,787Jul 31, 2026
Vanguard Extended Market Index Fund457KUS$7.46M+22,952Jun 30, 2026
iShares Russell 2000 Growth ETF404KUS$6.6M+85,839Jun 30, 2026
Show 50 holders
HolderSharesValueChangeAs of
Brown Advisory Small-Cap Growth Fund376KUS$6.14MNo changeJun 30, 2026
Champlain Small Company Fund340KUS$5.55M−75,865Jun 30, 2026
SmallCap Growth Fund I315KUS$5.6M+1,413Jul 31, 2026
Victory Small Cap Stock Fund300KUS$5.33M−3,236Jul 31, 2026
Embark Small Cap Equity Fund270KUS$4.8M+16,412Jul 31, 2026
Royce Smaller-Companies Growth Fund265KUS$4.32M+24,000Jun 30, 2026
Nuveen Small Cap Growth Opportunities Fund211KUS$3.75M+23,029Jul 31, 2026
Nuveen Small Cap Select Fund207KUS$3.68M−38,206Jul 31, 2026
Fidelity Extended Market Index Fund201KUS$2.83M−1,890May 31, 2026
Vanguard Russell 2000 Index Fund198KUS$2.79M+7,022May 31, 2026
Small Cap Growth Fund197KUS$2.77M−16,222May 31, 2026
Vela Small Cap Fund189KUS$3.09M+13,711Jun 30, 2026
iShares U.S. Medical Devices ETF185KUS$3.02M+18,768Jun 30, 2026
Schwab U.S. Small-Cap ETF183KUS$2.58M−2,834May 31, 2026
Allspring Small Company Growth Fund175KUS$3.12M−2,223Jul 31, 2026
iShares Micro-Cap ETF148KUS$2.41M+50,811Jun 30, 2026
Dimensional U.S. Small Cap ETF145KUS$2.58MNo changeJul 31, 2026
Victory RS Small Cap Growth Fund145KUS$2.37M−6,790Jun 30, 2026
Paradigm Micro-Cap Fund140KUS$2.28M+20,000Jun 30, 2026
U.S. Small Cap Portfolio134KUS$2.37M+11,604Jul 31, 2026
Optimum Small-Mid Cap Growth Fund133KUS$2.17M−5,106Jun 30, 2026
U.S. Micro Cap Portfolio130KUS$2.31M+18,212Jul 31, 2026
Vanguard Health Care Index Fund124KUS$1.75M+858May 31, 2026
Vanguard Explorer Fund119KUS$2.12M+56,189Jul 31, 2026
NYLIM VP Wellington Small Cap Portfolio119KUS$1.93M+1,483Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF115KUS$1.88M−14,525Jun 30, 2026
Schwab Small-Cap Index Fund107KUS$1.9M+23,944Jul 31, 2026
Adara Smaller Companies Fund98,593US$1.39M+11,911May 31, 2026
NYLIM VP Small Cap Growth Portfolio98,250US$1.6MNo changeJun 30, 2026
Master Small Cap Index Series82,218US$1.34M+17,296Jun 30, 2026
BlackRock Advantage Small Cap Core Fund80,266US$1.13M−1,077May 29, 2026
Brown Advisory Sustainable Small-Cap Core Fund78,347US$1.28M+6,785Jun 30, 2026
Fidelity Total Market Index Fund72,900US$1.03MNo changeMay 31, 2026
Principal U.S. Small-Cap ETF72,345US$1.18M+5,192Jun 30, 2026
Empower Small Cap Growth Fund67,025US$1.09M−6,004Jun 30, 2026
1290 Essex Small Cap Growth Fund65,789US$1.17M+16,204Jul 31, 2026
Fidelity Series Total Market Index Fund58,926US$831K+2,918May 31, 2026
State Street Institutional Small-Cap Equity Fund58,810US$960K+10,010Jun 30, 2026
Nuveen Small Cap Blend Index Fund58,219US$1.03M+15,592Jul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF56,925US$929K+1,360Jun 30, 2026

This page holds 50 of 175 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Francis Laura
Director, Officer: Chief Executive Officer
Sale1,901USD 23.18US$44,058Nov 17, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale1,715USD 23.19US$39,769Nov 17, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale3,892USD 23.33US$90,812Nov 16, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale2,235USD 23.33US$52,133Nov 16, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale3,203USD 23.32US$74,703Nov 16, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale3,651USD 23.33US$85,185Nov 16, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale1,972USD 23.32US$45,985Nov 16, 2026
Pisetsky Michael A.
Officer: Chief Legal Officer
Sale1,854USD 23.32US$43,240Nov 16, 2026
Pisetsky Michael A.
Officer: Chief Legal Officer
Sale1,871USD 23.31US$43,618Nov 16, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale2,476USD 23.31US$57,721Nov 16, 2026
Show 50 trades
InsiderTradeSharesPriceValueDate
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale2,189USD 23.34US$51,084Nov 16, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale12,349USD 25.08US$310KNov 4, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale23,892USD 24.78US$592KNov 4, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale75,000USD 25.30US$1.9MNov 4, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale36,241USD 24.80US$899KNov 4, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale3,247USD 25.00US$81,175Nov 4, 2026
Dunn Jeffrey W
Director
Sale20,000USD 20.89US$418KNov 2, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale29,665USD 22.11US$656KOct 29, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale3,738USD 22.50US$84,105Oct 29, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale38,006USD 20.05US$762KOct 12, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale1,731USD 19.50US$33,755Oct 5, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale1,300USD 18.20US$23,664Oct 2, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale1,799USD 18.14US$32,637Oct 2, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale34USD 18.14US$617Oct 2, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale1,560USD 18.17US$28,341Oct 2, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale1,758USD 18.19US$31,984Oct 2, 2026
Dunn Jeffrey W
Director
Sale20,000USD 18.47US$369KOct 1, 2026
Dunn Jeffrey W
Director
Sale18,633USD 18.91US$352KSep 1, 2026
Dunn Jeffrey W
Director
Sale1,367USD 18.91US$25,850Sep 1, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale25,972USD 20.12US$523KAug 24, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale11,636USD 20.11US$234KAug 24, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale3,923USD 20.02US$78,538Aug 21, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale11,228USD 20.02US$225KAug 21, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale51,884USD 19.46US$1.01MAug 20, 2026
Maheshwari Anshul
Officer: Chief Op & Financial Officer
Sale5,747USD 19.55US$112KAug 19, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale3,892USD 18.66US$72,625Aug 17, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale3,652USD 18.66US$68,146Aug 17, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale3,203USD 18.66US$59,768Aug 17, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale2,236USD 18.68US$41,768Aug 17, 2026
Francis Laura
Director, Officer: Chief Executive Officer
Sale1,973USD 18.63US$36,757Aug 17, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale1,854USD 18.62US$34,521Aug 17, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale1,871USD 18.65US$34,894Aug 17, 2026
Maheshwari Anshul
Officer: Chief Financial Officer
Sale2,476USD 18.68US$46,252Aug 17, 2026
Maheshwari Anshul
Officer: Chief Financial Officer
Sale2,189USD 18.62US$40,759Aug 17, 2026
Dunn Jeffrey W
Director
Sale20,000USD 18.46US$369KAug 3, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale1,799USD 16.70US$30,043Jul 2, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale34USD 16.86US$573Jul 2, 2026
Pisetsky Michael A.
Officer: SVP, Ops & Adm/Chief Legal Ofr
Sale1,301USD 16.73US$21,766Jul 2, 2026
Maheshwari Anshul
Officer: Chief Financial Officer
Sale1,757USD 16.80US$29,518Jul 2, 2026
Maheshwari Anshul
Officer: Chief Financial Officer
Sale1,560USD 16.73US$26,099Jul 2, 2026

This page holds 50 of 68 trades. Open Shareholders

Big stakes

HolderStakeSharesDate
First Light Asset Management, LLC18.36%8.12MApr 30, 2026
BlackRock, Inc.8.00%3.56MJun 30, 2026
Cadian Capital Management, LP7.50%3.35MJun 30, 2026
American Century Investment Management, Inc.5.30%2.3MDec 31, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Bonita
Other companies: Windward Bio Group AG (Director · Since at least Nov 16, 2026); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); ImageneBio, Inc. (Director · Since at least Mar 25, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 15, 2023 · Past); Repare Therapeutics Inc (Director · Jun 18, 2020 – Jun 17, 2024 · Past); Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 2, 2022 · Past); Tricida Inc (Director · Jun 27, 2018 – Nov 22, 2022 · Past); Loxo Oncology Inc (Director · Jul 31, 2014 – Dec 8, 2017 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – May 15, 2014 · Past)
Director · Oct 16, 2018 – Oct 19, 2018 · Past
John G. Freund
Other companies: Collegium Pharmaceutical, Inc. (Director · Since at least May 6, 2015); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Jun 6, 2024 · Past); Protara Therapeutics, Inc. (Director · Oct 21, 2014 – Nov 8, 2019 · Past); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Dec 10, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Hansen Medical Inc (Director · Nov 15, 2006 – Jun 17, 2009 · Past); XenoPort Inc (Director · May 2, 2006 – Jul 5, 2016 · Past)
Director · Since at least Oct 16, 2018
Jeryl Jeri Hilleman
Other companies: Omada Health, Inc. (Director · Since at least Jun 5, 2025); NovoCure Limited (Director · Since at least Jun 8, 2022); Hillevax Inc (Director · Since at least Apr 28, 2022); Cutera Inc (Director · Jul 12, 2024 – Oct 24, 2024 · Past); Minerva Neurosciences, Inc (Director · Jun 10, 2022 – Sep 27, 2023 · Past)
Director · Since at least Jun 13, 2022
Keith Valentine
Other companies: Regentis Biomaterials Ltd. (Director · Since at least Mar 18, 2026); Alphatec Holdings, Inc. (Director · Since at least Jul 29, 2024); Orthofix Medical Inc. (President & CEO, Director · Jan 5, 2023 – Feb 28, 2023 · Past); SeaSpine Holdings Corp (Chief Executive Officer, Director · Jun 11, 2015 – Jan 5, 2023 · Past); NuVasive Inc (COO · Jan 3, 2006 – Jan 27, 2015 · Past)
Director · Oct 16, 2018 – Jun 9, 2023 · Past
Thomas A. West
Other companies: CeriBell, Inc. (Director · Since at least Jul 28, 2026); Inogen, Inc (Director · Apr 1, 2023 – Jun 5, 2024 · Past); Orthofix Medical Inc. (Director · Dec 13, 2021 – Dec 31, 2022 · Past); Intersect ENT Inc (President and CEO, Director · Jul 22, 2019 – May 13, 2022 · Past); Hologic Inc (Div President & GM, Diagnostic · Oct 3, 2014 – Dec 1, 2018 · Past)
Director · Since at least Jun 25, 2024
Gregory K Hinckley
Other companies: Bio-Rad Laboratories, Inc. (Director · Since at least Apr 25, 2017); Super Micro Computer, Inc. (Director · Feb 8, 2011 – Feb 10, 2015 · Past); Mentor Graphics Corp (President · Sep 15, 2010 – Mar 30, 2017 · Past); Intermec Inc (Director · May 26, 2010 – Sep 17, 2013 · Past)
Director · Since at least Oct 16, 2018
Heyward R Donigan
Other companies: Rite Aid Corporation (President and CEO · Aug 12, 2019 – Aug 12, 2022 · Past); NxStage Medical Inc (Director · Jul 15, 2016 – Feb 21, 2019 · Past); Kindred Healthcare Inc (Director · Mar 26, 2014 – Jul 2, 2018 · Past)
Director · Jun 13, 2019 – Jun 13, 2019 · Past
Laura Francis
Other companies: Bruker Corporation (Director · Since at least Feb 18, 2025); Shockwave Medical Inc (Director · Mar 6, 2019 – May 31, 2024 · Past)
Chief Executive Officer · Since at least Oct 16, 2018
Mark J. Foley
Other companies: Glaukos Corporation (Director · Since at least Dec 13, 2017); Revance Therapeutics, Inc. (President & CEO, Director · Nov 7, 2017 – Feb 4, 2025 · Past)
Director · Jun 13, 2019 – Jun 16, 2020 · Past
Joe Kostka
Other companies: Bruker Corporation (Investor Relations · Since at least Dec 10, 2025)
Director, Investor Relations · Feb 21, 2025 – Nov 4, 2026 · Past
All 27 people
PersonSeat
Karen A Licitra
Other companies: AngioDynamics, Inc. (Director · Since at least Jul 17, 2019)
Director · Oct 16, 2018 – Jun 25, 2021 · Past
Mika Nishimura
Other companies: Accuray Incorporated (Director · Since at least Aug 17, 2021)
Director · Since at least Mar 4, 2021
Timothy Petersen
Other companies: Inogen, Inc (Director · Feb 12, 2014 – May 29, 2015 · Past)
Director · Oct 16, 2018 – Oct 19, 2018 · Past
Anshul MaheshwariChief Op & Financial Officer · Since at least May 16, 2022
Anthony J RecuperoPresident, Commercial Ops · Since at least Oct 16, 2018
ContactSaqib IqbalSrDirector, FP&A and Investor Relations · Jan 13, 2025 – Nov 4, 2026 · Past
Daniel W WolfDirector · Since at least Aug 5, 2024
Helen LohDirector · Jun 16, 2022 – Jun 9, 2023 · Past
Jeffrey W. DunnChairman of the Board · Since at least Oct 16, 2018
Mark ReileyFounder · Since at least Nov 4, 2026
Michael A PisetskyChief Legal Officer · Since at least Apr 18, 2022
Saqib IqbalSrDirector, FP&A and Investor Relations · Feb 24, 2025 – Nov 4, 2026 · Past
Scott A YerbyChief Technology Officer · Oct 16, 2018 – Jan 15, 2020 · Past
Timothy E. DavisDirector · Since at least Jun 8, 2026
Timothy E Davis JrDirector · Since at least Oct 16, 2018
Troy WahlenmaierChief Commercial Officer · Aug 14, 2025 – Nov 4, 2026 · Past
W Carlton RecklingCMO and VP, Medical Affairs · Oct 16, 2018 – Jan 15, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about SI-BONE, Inc.